SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination

Little is known about the cellular immune response to SARS‐CoV‐2 vaccination in patients after HSCT and B‐NHL with iatrogenic B‐cell aplasia. In nonseroconverted HSCT patients, induction of specific T‐cell responses was assessed. The majority of allogeneic HSCT patients not showing humoral responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarisch, Andrea, Wiercinska, Eliza, Daqiq‐Mirdad, Shabnam, Hellstern, Helen, Ajib, Salem, Cremer, Anjali, Nguyen, Ngoc Thien Thu, Dukat, Alexandra, Ullrich, Evelyn, Ciesek, Sandra, Chow, Kai‐Uwe, Serve, Hubert, Seifried, Erhard, Bader, Peter, Bonig, Halvard, Bug, Gesine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Notes and Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087431/
https://www.ncbi.nlm.nih.gov/pubmed/35389515
http://dx.doi.org/10.1002/eji.202149771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087431/
https://www.ncbi.nlm.nih.gov/pubmed/35389515
http://dx.doi.org/10.1002/eji.202149771

Ejemplares similares